Luteinizing hormone (LH)-responsive cushing's syndrome: The demonstration of LH receptor messenger ribonucleic acid in hyperplastic adrenal cells, which respond to chorionic gonadotropin and serotonin agonists in vitro

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 1, 2003, Pages 230-237

  Feelders, Richard A ^a   Lamberts, Steven W J ^a   Hofland, Leo J ^a   Van Koetsveld, Peter M ^a   Verhoef Post, Miriam ^a   Themmen, Axel P N ^a   De Jong, Frank H ^a   Bonjer, H Jaap ^a   Clark, Adrian J ^b   Van Der Lely, Aart Jan ^a   De Herder, Wouter W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b St B/the R L S of M/D ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; CISAPRIDE; CORTICOTROPIN; CORTICOTROPIN RECEPTOR; DEXAMETHASONE; HYDROCORTISONE; LUTEINIZING HORMONE; LUTEINIZING HORMONE RECEPTOR; MESSENGER RNA; METOCLOPRAMIDE; SEROTONIN; SEROTONIN AGONIST;

ADRENAL CELL; ADRENAL HYPERPLASIA; ADRENALECTOMY; ADULT; ARTICLE; CASE REPORT; CIRCADIAN RHYTHM; CUSHING SYNDROME; DOSE RESPONSE; DRUG RESPONSE; ENDOCRINE FUNCTION TEST; FEMALE; GENE MUTATION; HORMONE DEPENDENCE; HORMONE SYNTHESIS; HUMAN; HYDROCORTISONE RELEASE; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; RECEPTOR GENE;

ADRENAL GLANDS; ADRENOCORTICAL HYPERFUNCTION; ADRENOCORTICOTROPIC HORMONE; ADULT; CHORIONIC GONADOTROPIN; CISAPRIDE; FEMALE; HORMONES; HUMANS; HYPERPLASIA; LUTEINIZING HORMONE; METOCLOPRAMIDE; MIDDLE AGED; RECEPTORS, LH; RNA, MESSENGER; SEROTONIN AGONISTS;

EID: 0037238467     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-020621     Document Type: Article

References (22)

1. Lacroix A, Ndiaye N, Tremblay J, Hamet P 2001 Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome. Endocr Rev 22:75-110
2. Lacroix A, Hamet P, Boutin JM 1999 Leuprolide acetate therapy in luteinizing hormone-dependent Cushing's syndrome. N Engl J Med 341:1577-1581
3. Kartheuser A, Walon C, West S, Breukel C, Detry R, Gribomont AC, Hamzehloei T, Hoang P, Maiter D, Pringot J, Rahier J, Meera Khan P, Curtis A, Burn J, Fodde R, Verellen-Dumoulin C 1999 Familial adenomatous polyposis associated with multiple adrenal adenomas in a patient with a rare 3′ APC mutation. J Med Genet 36:65-67
4. Marzouk HF, Zuyderwijk J, Uitterlinden P, de Jong FH, Lamberts SWJ 1990 Suramin prevents ACTH-stimulated corticosterone release by dispersed adrenocortical cells. Endocrinology 126:666-668
5. Richardson MC, Schulster D 1972 Corticosteroidogenesis in isolated adrenal cells: effect of adrenocorticotrophtc hormone, adenosine 3′, 5′-monophosphate and 1-24 adrenocorticotrophic hormone diazotized to polyacrylamide. J Endocrinol 55:127-139
6. Blok LJ, Bartlett JM, Bolt-De Vries J, Themmen APN, Brinkmann AO, Weinbauer GF, Nieschlag E, Grootegoed JA 1992 Effect of testosterone deprivation on expression of the androgen receptor in rat prostate, epididymis and testis. Int J Androl 15:182-198
7. Van Schaik RHM, Wierikx CDJ, Looijenga LHJ, Oosterhuis JW, de Jong FH 1997 Human testicular germ cell tumours express inhibin subunits, activin receptors and follistatin mRNAs. Br J Cancer 76:1191-1198
8. Martens JWM, Verhoef-Post M, Abelin N, Ezabella M, Toledo SP, Brunner HG, Themmen APN 1998 A homozygous mutation in the luteinizing hormone receptor causes partial Leydig cell hypoplasia: correlation between receptor activity and phenotype. Mol Endocrinol 12:775-784
9. Himmler A, Stratowa C, Czernilofsky AP 1993 Functional testing of human dopamine D1 and D5 receptors expressed in stable cAMP-responsive luciferase reporter cell lines. J Recept Res 13:79-94
10. Elias LL, Huebner A, Pullinger GD, Mirtella A, Clark AJ 1999 Functional characterization of naturally occurring mutations of the human adrenocorticotropin receptor: poor correlation of phenotype and genotype. J Clin Endocrinol Metab 84:2766-2770
11. Biemond P, de Jong FH, Lamberts SWJ 1990 Continuous dexamethasone infusion for seven hours in patients with the Cushing's syndrome. A superior differential diagnostic test. Ann Intern Med 112:738-742
12. Rao CV 1996 The beginning of a new era in reproductive biology and medicine: expression of low levels of functional luteinizing hormone/human chorionic gonadotropin receptors in nongonadal tissues. J Physiol Pharmacol 47(Suppl): 41-53
13. Pabon JE, Li X, Lei ZM, Sanfilippo JS, Yussman MA, Rao CV 1996 Novel presence of luteinizing hormone/chorionic gonadotropin receptors in human adrenal glands. J Clin Endocrinol Metab 81:2397-2400
14. Seron-Ferre M, Lawrence CC, Jaffe RB 1978 Role of hCG in regulation of the fetal zone of the human fetal adrenal gland. J Clin Endocrinol Metab 46: 834-837
15. O'Connell Y, McKenna TJ, Cunningham SK 1994 The effect of prolactin, human chorionic gonadotropin, insulin and insulin-like growth factor 1 on adrenal steroidogenesis in isolated guinea-pig adrenal cells. J Steroid Biochem Mol Biol 48:235-240
16. Franks S 1995 Polycystic ovary syndrome. N Engl J Med 333:853-861
17. Kero J, Poutanen M, Zhang FP, Rahman N, McNicol AM, Nilson JH, Keri RA, Huhtaniemi IT 2000 Elevated luteinizing hormone induces expression of its receptor and promotes steroidogenesis in the adrenal cortex. J Clin Invest 105:633641
18. Schoemaker NJ, Schuurmans M, Moorman H, Lumeij JT 2000 Correlation between age at neutering and age at onset of hyperadrenocorticism in ferrets. J Am Vet Med Assoc 216:195-197
19. Wagner RA, Bailey EM, Schneider JF, Oliver JW 2001 Leuprolide acetate treatment of adrenocortical disease in ferrets. J Am Vet Med Assoc 218:1272-1274
20. Bourdeau I, D'Amour P, Hamet P, Boutin JM, Lacroix A 2001 Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing's syndrome. J Clin Endocrinol Metab 86:5534-5540
21. Lefebvre H, Contesse V, Delarue C, Vaudry H, Kuhn JM 1998 Serotonergic regulation of adrenocortical function. Horm Metab Res 30:398-403
22. 4, 5-hydroxy-tryptamine receptor type 4; PRL, prolactin; RNase, ribonuclease.